Media Coverage
June 24th, 2022

What do you consider the biggest challenge that the pharma/biopharma industry currently faces?

June 23rd, 2022

The Next Chapter: Harnessing Big Data in Pharma with Computational Disease Models

Media Coverage
April 13th, 2022

CytoReason expands reach in Asia, leveraging ML in drug development for Korean drugmakers

Media Coverage
April 12th, 2022

Israel’s CytoReason, S. Korea’s Helixrus partner on machine learning for drug development

Press Release
April 12th, 2022

CytoReason Expands Its Reach in Asia, Forging Commercial Alliance with Helixrus to Leverage Machine Learning in Drug Development for Korean Drugmakers

Media Coverage
March 29th, 2022

Poolbeg signs deal with Cytoreason on influenza drug development

Bring your data to life